2022 Q1 Form 10-Q Financial Statement
#000190163722000004 Filed on May 12, 2022
Income Statement
Concept | 2022 Q1 | 2021 Q4 | 2021 Q1 |
---|---|---|---|
Revenue | $15.34M | $13.73M | |
YoY Change | 11.76% | ||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | $387.0K | $508.0K | |
YoY Change | -23.82% | ||
% of Gross Profit | |||
Depreciation & Amortization | $188.0K | $190.0K | $330.0K |
YoY Change | -43.03% | -40.63% | 6.45% |
% of Gross Profit | |||
Operating Expenses | $387.0K | $508.0K | |
YoY Change | -23.82% | ||
Operating Profit | |||
YoY Change | |||
Interest Expense | $963.0K | $1.253M | |
YoY Change | -23.14% | ||
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $6.712M | $7.400M | $6.279M |
YoY Change | 6.9% | 57.78% | 173.0% |
Income Tax | $1.858M | $1.750M | $1.498M |
% Of Pretax Income | 27.68% | 23.65% | 23.86% |
Net Earnings | $4.854M | $5.650M | $4.781M |
YoY Change | 1.53% | 33.25% | 174.77% |
Net Earnings / Revenue | 31.64% | 34.83% | |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $241.4K | $1.066M | $239.1K |
COMMON SHARES | |||
Basic Shares Outstanding | 20.00M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q1 | 2021 Q4 | 2021 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $94.11M | $46.23M | $105.9M |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | |||
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $18.69M | $5.278M | $20.00M |
YoY Change | -6.57% | -16.84% | |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $38.86M | $34.90M | $39.20M |
YoY Change | -0.87% | -10.97% | |
Total Long-Term Assets | |||
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | |||
Total Long-Term Assets | |||
Total Assets | $1.967B | $1.854B | $1.633B |
YoY Change | 20.44% | 23.45% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $23.64M | $22.20M | $21.70M |
YoY Change | 8.95% | 6.73% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $23.64M | $22.20M | $21.70M |
YoY Change | 8.95% | 6.73% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $2.277M | $1.400M | $1.000M |
YoY Change | 127.7% | 180.0% | |
Total Long-Term Liabilities | $2.277M | $1.400M | $1.000M |
YoY Change | 127.7% | 180.0% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $23.64M | $22.20M | $21.70M |
Total Long-Term Liabilities | $2.277M | $1.400M | $1.000M |
Total Liabilities | $1.775B | $1.650B | $1.463B |
YoY Change | 21.35% | 23.99% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$119.4M | -$124.2M | |
YoY Change | 131.71% | ||
Common Stock | |||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $192.0M | $203.9M | $170.4M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $1.967B | $1.854B | $1.633B |
YoY Change | 20.44% | 23.45% |
Cashflow Statement
Concept | 2022 Q1 | 2021 Q4 | 2021 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $4.854M | $5.650M | $4.781M |
YoY Change | 1.53% | 33.25% | 174.77% |
Depreciation, Depletion And Amortization | $188.0K | $190.0K | $330.0K |
YoY Change | -43.03% | -40.63% | 6.45% |
Cash From Operating Activities | $5.603M | -$1.600M | $4.059M |
YoY Change | 38.04% | 14.29% | 479.86% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $155.0K | -$320.0K | $184.0K |
YoY Change | -15.76% | 300.0% | -304.44% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$80.58M | -$127.1M | -$75.72M |
YoY Change | 6.42% | -11.24% | -320.76% |
Cash From Investing Activities | -$80.74M | -$127.4M | -$75.90M |
YoY Change | 6.37% | -11.07% | -321.87% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | $781.0K | ||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $102.0K | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $123.0M | 105.7M | $130.0M |
YoY Change | -5.41% | 603.53% | 584.46% |
NET CHANGE | |||
Cash From Operating Activities | $5.603M | -1.600M | $4.059M |
Cash From Investing Activities | -$80.74M | -127.4M | -$75.90M |
Cash From Financing Activities | $123.0M | 105.7M | $130.0M |
Net Change In Cash | $47.89M | -23.36M | $58.21M |
YoY Change | -17.73% | -81.99% | 7.97% |
FREE CASH FLOW | |||
Cash From Operating Activities | $5.603M | -$1.600M | $4.059M |
Capital Expenditures | $155.0K | -$320.0K | $184.0K |
Free Cash Flow | $5.448M | -$1.280M | $3.875M |
YoY Change | 40.59% | -3.03% | 390.51% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
102000 | USD |
CY2021Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
781000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
122915000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
130829000 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
123017000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
130048000 | USD |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
47885000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
58206000 | USD |
CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
961000 | USD |
CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1042000 | USD |
CY2022Q1 | us-gaap |
Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
|
3309000 | USD |
CY2021Q1 | us-gaap |
Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
|
8824000 | USD |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
94113000 | USD |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
46228000 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
47734000 | USD |
CY2021Q4 | us-gaap |
Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
|
0.1370 | pure |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
105940000 | USD |
CY2021Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
15057000 | USD |
CY2022Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2022Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2022Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022Q1 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
112690000 | USD |
CY2021Q4 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
120157000 | USD |
CY2022Q1 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
15074000 | USD |
CY2022Q1 | uscb |
Time Deposits Less Than250000
TimeDepositsLessThan250000
|
104962000 | USD |
CY2021Q4 | uscb |
Time Deposits Less Than250000
TimeDepositsLessThan250000
|
105819000 | USD |
CY2022Q1 | uscb |
Advances Federal Home Loan Bank
AdvancesFederalHomeLoanBank
|
36000000 | USD |
CY2021Q4 | uscb |
Advances Federal Home Loan Bank
AdvancesFederalHomeLoanBank
|
36000000 | USD |
CY2022Q1 | uscb |
Accrued Interest And Other Liabilities
AccruedInterestAndOtherLiabilities
|
12478000 | USD |
CY2021Q4 | uscb |
Accrued Interest And Other Liabilities
AccruedInterestAndOtherLiabilities
|
9478000 | USD |
CY2022Q1 | us-gaap |
Liabilities
Liabilities
|
1775213000 | USD |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
1650042000 | USD |
CY2022Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
310887000 | USD |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
310666000 | USD |
CY2022Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-119391000 | USD |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-124245000 | USD |
CY2022Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-19458000 | USD |
CY2021Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-2516000 | USD |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
192039000 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
203897000 | USD |
CY2022Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1967252000 | USD |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1853939000 | USD |
CY2022Q1 | us-gaap |
Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
|
12982000 | USD |
CY2021Q1 | us-gaap |
Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
|
11868000 | USD |
CY2022Q1 | us-gaap |
Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
|
2329000 | USD |
CY2021Q1 | us-gaap |
Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
|
1844000 | USD |
CY2022Q1 | us-gaap |
Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
|
31000 | USD |
CY2021Q1 | us-gaap |
Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
|
16000 | USD |
CY2022Q1 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
15342000 | USD |
CY2021Q1 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
13728000 | USD |
CY2022Q1 | uscb |
Interest Expense Interest Bearing Deposits
InterestExpenseInterestBearingDeposits
|
16000 | USD |
CY2021Q1 | uscb |
Interest Expense Interest Bearing Deposits
InterestExpenseInterestBearingDeposits
|
14000 | USD |
CY2022Q1 | us-gaap |
Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
|
551000 | USD |
CY2021Q1 | us-gaap |
Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
|
548000 | USD |
CY2022Q1 | us-gaap |
Interest Expense Time Deposits
InterestExpenseTimeDeposits
|
259000 | USD |
CY2021Q1 | us-gaap |
Interest Expense Time Deposits
InterestExpenseTimeDeposits
|
554000 | USD |
CY2022Q1 | us-gaap |
Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
|
137000 | USD |
CY2021Q1 | us-gaap |
Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
|
137000 | USD |
CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
963000 | USD |
CY2021Q1 | us-gaap |
Interest Expense
InterestExpense
|
1253000 | USD |
CY2022Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
14379000 | USD |
CY2021Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
12475000 | USD |
CY2021Q1 | us-gaap |
Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
|
160000 | USD |
CY2022Q1 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
14379000 | USD |
CY2021Q1 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
12635000 | USD |
CY2022Q1 | us-gaap |
Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
|
900000 | USD |
CY2021Q1 | us-gaap |
Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
|
889000 | USD |
CY2022Q1 | us-gaap |
Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
|
21000 | USD |
CY2021Q1 | us-gaap |
Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
|
62000 | USD |
CY2022Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
334000 | USD |
CY2021Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
964000 | USD |
CY2022Q1 | uscb |
Loan Settlement
LoanSettlement
|
161000 | USD |
CY2022Q1 | us-gaap |
Noninterest Income Other
NoninterestIncomeOther
|
529000 | USD |
CY2021Q1 | us-gaap |
Noninterest Income Other
NoninterestIncomeOther
|
406000 | USD |
CY2022Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
1945000 | USD |
CY2021Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
2321000 | USD |
CY2022Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
5875000 | USD |
CY2021Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
5278000 | USD |
CY2022Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
1270000 | USD |
CY2021Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
1387000 | USD |
CY2022Q1 | uscb |
Regulatory Assessment And Fees
RegulatoryAssessmentAndFees
|
213000 | USD |
CY2021Q1 | uscb |
Regulatory Assessment And Fees
RegulatoryAssessmentAndFees
|
178000 | USD |
CY2022Q1 | us-gaap |
Legal Fees
LegalFees
|
517000 | USD |
CY2021Q1 | us-gaap |
Legal Fees
LegalFees
|
185000 | USD |
CY2022Q1 | us-gaap |
Communications And Information Technology
CommunicationsAndInformationTechnology
|
387000 | USD |
CY2021Q1 | us-gaap |
Communications And Information Technology
CommunicationsAndInformationTechnology
|
508000 | USD |
CY2022Q1 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
1350000 | USD |
CY2021Q1 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
1141000 | USD |
CY2022Q1 | us-gaap |
Noninterest Expense
NoninterestExpense
|
9612000 | USD |
CY2021Q1 | us-gaap |
Noninterest Expense
NoninterestExpense
|
8677000 | USD |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
6712000 | USD |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
6279000 | USD |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1858000 | USD |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1498000 | USD |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4854000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4781000 | USD |
CY2021Q1 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
781000 | USD |
CY2022Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
4854000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
4000000 | USD |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4854000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4781000 | USD |
CY2022Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
-22775000 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
-6070000 | USD |
CY2022Q1 | us-gaap |
Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax
OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax
|
65000 | USD |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
21000 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
62000 | USD |
CY2022Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
|
-5789000 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
|
-1503000 | USD |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-16942000 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-4629000 | USD |
CY2022Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-12088000 | USD |
CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
152000 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
203897000 | USD |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4854000 | USD |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-16942000 | USD |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
102000 | USD |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
128000 | USD |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
192039000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4781000 | USD |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-4629000 | USD |
CY2021Q1 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
781000 | USD |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
53000 | USD |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4854000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4781000 | USD |
CY2021Q1 | us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
-160000 | USD |
CY2022Q1 | uscb |
Depreciation And Amortization1
DepreciationAndAmortization1
|
188000 | USD |
CY2021Q1 | uscb |
Depreciation And Amortization1
DepreciationAndAmortization1
|
329000 | USD |
CY2022Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-169000 | USD |
CY2021Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-54000 | USD |
CY2022Q1 | us-gaap |
Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
|
807000 | USD |
CY2021Q1 | us-gaap |
Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
|
1249000 | USD |
CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
128000 | USD |
CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
53000 | USD |
CY2022Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
21000 | USD |
CY2021Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
62000 | USD |
CY2022Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
334000 | USD |
CY2021Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
964000 | USD |
CY2022Q1 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
266000 | USD |
CY2021Q1 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
170000 | USD |
CY2022Q1 | uscb |
Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
|
-1858000 | USD |
CY2021Q1 | uscb |
Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
|
-1498000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
328000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
462000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
2838000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
1660000 | USD |
CY2022Q1 | uscb |
Increase Decrease In Accrued Interest And Other Liabilities
IncreaseDecreaseInAccruedInterestAndOtherLiabilities
|
3000000 | USD |
CY2021Q1 | uscb |
Increase Decrease In Accrued Interest And Other Liabilities
IncreaseDecreaseInAccruedInterestAndOtherLiabilities
|
2071000 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
5603000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
4059000 | USD |
CY2022Q1 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
2432000 | USD |
CY2022Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
|
2626000 | USD |
CY2022Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
42794000 | USD |
CY2021Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
41094000 | USD |
CY2022Q1 | uscb |
Proceeds From Maturities And Prepayments Of Available For Sale Securities
ProceedsFromMaturitiesAndPrepaymentsOfAvailableForSaleSecurities
|
14788000 | USD |
CY2021Q1 | uscb |
Proceeds From Maturities And Prepayments Of Available For Sale Securities
ProceedsFromMaturitiesAndPrepaymentsOfAvailableForSaleSecurities
|
13699000 | USD |
CY2022Q1 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
14558000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
14248000 | USD |
CY2022Q1 | us-gaap |
Payments For Proceeds From Other Loans And Leases
PaymentsForProceedsFromOtherLoansAndLeases
|
617000 | USD |
CY2021Q1 | us-gaap |
Payments For Proceeds From Other Loans And Leases
PaymentsForProceedsFromOtherLoansAndLeases
|
72969000 | USD |
CY2022Q1 | us-gaap |
Payments To Acquire Loans And Leases Held For Investment
PaymentsToAcquireLoansAndLeasesHeldForInvestment
|
70175000 | USD |
CY2022Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
155000 | USD |
CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
184000 | USD |
CY2022Q1 | us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
3643000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
9788000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
|
611000 | USD |
CY2022Q1 | us-gaap |
Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
|
177000 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-80735000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-75901000 | USD |
CY2022Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
102000 | USD |
CY2021Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
781000 | USD |
CY2022Q1 | us-gaap |
Escrow Deposit
EscrowDeposit
|
30300000 | USD |
CY2022Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
122915000 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
130829000 | USD |
CY2021Q4 | us-gaap |
Escrow Deposit
EscrowDeposit
|
28900000 | USD |
CY2022Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
14558000 | USD |
CY2021Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
14248000 | USD |
CY2022Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
|
158000 | USD |
CY2021Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
|
75000 | USD |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
123017000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
130048000 | USD |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
47885000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
58206000 | USD |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
46228000 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
47734000 | USD |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
94113000 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
105940000 | USD |
CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
961000 | USD |
CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1042000 | USD |
CY2022Q1 | us-gaap |
Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
|
3309000 | USD |
CY2021Q1 | us-gaap |
Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
|
8824000 | USD |
CY2021Q4 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
|
2515000 | USD |
CY2021Q4 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
120157000 | USD |
CY2022Q1 | us-gaap |
Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax
OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax
|
65000 | USD |
CY2022Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div id="TextBlockContainer223" style="position:relative;font-family:'Arial';font-size:13.28px;color:#000000;line-height:normal;width:735px;height:261px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2703" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Concentration of Credit Risks </div><div id="a2706" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:31px;">Credit<div style="display:inline-block;width:5px"> </div>risk<div style="display:inline-block;width:5px"> </div>represents<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:6px"> </div>accounting<div style="display:inline-block;width:6px"> </div>loss<div style="display:inline-block;width:5px"> </div>that<div style="display:inline-block;width:5px"> </div>would<div style="display:inline-block;width:6px"> </div>be<div style="display:inline-block;width:5px"> </div>recognized<div style="display:inline-block;width:6px"> </div>at<div style="display:inline-block;width:5px"> </div>the<div style="display:inline-block;width:5px"> </div>reporting<div style="display:inline-block;width:6px"> </div>date<div style="display:inline-block;width:5px"> </div>if<div style="display:inline-block;width:5px"> </div>counterparties<div style="display:inline-block;width:6px"> </div>failed<div style="display:inline-block;width:5px"> </div>to </div><div id="a2707" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:46px;">perform as contracted and any collateral or security proved to be insufficient<div style="display:inline-block;width:5px"> </div>to cover the loss. Concentrations of credit risk </div><div id="a2709" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:61px;">(whether on or off-balance sheet) arising from financial instruments exist in relation to certain<div style="display:inline-block;width:2px"> </div>groups of customers. A group </div><div id="a2712" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:77px;">concentration arises when<div style="display:inline-block;width:6px"> </div>a number of<div style="display:inline-block;width:5px"> </div>counterparties have<div style="display:inline-block;width:5px"> </div>similar economic characteristics<div style="display:inline-block;width:6px"> </div>that would cause<div style="display:inline-block;width:5px"> </div>their ability </div><div id="a2714" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:92px;">to meet contractual obligations to be similarly affected by changes in economic or other conditions. The Company does not </div><div id="a2715" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:107px;">have a significant exposure to any individual customer<div style="display:inline-block;width:5px"> </div>or counterparty. </div><div id="a2719" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:138px;">At March<div style="display:inline-block;width:5px"> </div>31, 2022<div style="display:inline-block;width:6px"> </div>and<div style="display:inline-block;width:5px"> </div>December 31,<div style="display:inline-block;width:5px"> </div>2021, the<div style="display:inline-block;width:6px"> </div>Company<div style="display:inline-block;width:5px"> </div>had<div style="display:inline-block;width:5px"> </div>a concentration<div style="display:inline-block;width:7px"> </div>of risk<div style="display:inline-block;width:6px"> </div>with loans<div style="display:inline-block;width:6px"> </div>outstanding<div style="display:inline-block;width:5px"> </div>to the </div><div id="a2727" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:153px;">Company’s<div style="display:inline-block;width:7px"> </div>top<div style="display:inline-block;width:6px"> </div>ten<div style="display:inline-block;width:7px"> </div>lending<div style="display:inline-block;width:7px"> </div>relationships<div style="display:inline-block;width:7px"> </div>totaling<div style="display:inline-block;width:7px"> </div>$</div><div id="a2727_50_5" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:153px;">187.1</div><div id="a2727_55_14" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:349px;top:153px;"><div style="display:inline-block;width:6px"> </div>million<div style="display:inline-block;width:7px"> </div>and<div style="display:inline-block;width:7px"> </div>$</div><div id="a2727_69_5" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:153px;">156.4</div><div id="a2727_74_44" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:470px;top:153px;"><div style="display:inline-block;width:7px"> </div>million,<div style="display:inline-block;width:7px"> </div>respectively,<div style="display:inline-block;width:8px"> </div>at<div style="display:inline-block;width:7px"> </div>such<div style="display:inline-block;width:7px"> </div>dates.<div style="display:inline-block;width:7px"> </div>This </div><div id="a2748" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">concentration accounted for </div><div id="a2748_28_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:173px;top:169px;">14.9</div><div id="a2748_32_49" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:199px;top:169px;">% of net loans outstanding at March 31, 2022 and </div><div id="a2748_81_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:169px;">13.1</div><div id="a2748_85_24" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:523px;top:169px;">% at December 31, 2021. </div><div id="a2772" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:199px;">At March 31, 2022 and December 31, 2021, the<div style="display:inline-block;width:2px"> </div>Company also had a concentration of credit<div style="display:inline-block;width:2px"> </div>risk with loans outstanding </div><div id="a2781" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:215px;">to foreign banks in Ecuador, Honduras, and El<div style="display:inline-block;width:2px"> </div>Salvador totaling $</div><div id="a2781_65_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:215px;">61.4</div><div id="a2781_69_14" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:215px;"><div style="display:inline-block;width:4px"> </div>million and $</div><div id="a2781_83_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:491px;top:215px;">47.9</div><div id="a2781_87_39" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:215px;"><div style="display:inline-block;width:3px"> </div>million, respectively, at such dates. </div><div id="a2791" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:230px;">These foreign banks maintained deposits<div style="display:inline-block;width:5px"> </div>with right of offset totaling<div style="display:inline-block;width:5px"> </div>$</div><div id="a2791_71_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:230px;">30.3</div><div id="a2791_75_14" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:230px;"><div style="display:inline-block;width:4px"> </div>million and $</div><div id="a2791_89_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:520px;top:230px;">28.9</div><div id="a2791_93_31" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:230px;"><div style="display:inline-block;width:4px"> </div>million at March 31, 2022 and </div><div id="a2809" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:245px;">December 31, 2021, respectively. </div></div><div id="TextBlockContainer227" style="position:relative;font-family:'Arial';font-size:13.28px;color:#000000;line-height:normal;width:735px;height:63px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2841" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:15px;">At various times during<div style="display:inline-block;width:5px"> </div>the year,<div style="display:inline-block;width:5px"> </div>the Company has maintained<div style="display:inline-block;width:5px"> </div>deposits with other<div style="display:inline-block;width:5px"> </div>financial institutions. The exposure </div><div id="a2842" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:31px;">to the Company from<div style="display:inline-block;width:2px"> </div>these transactions is solely<div style="display:inline-block;width:2px"> </div>dependent upon daily balances<div style="display:inline-block;width:2px"> </div>and the financial strength<div style="display:inline-block;width:2px"> </div>of the respective </div><div id="a2844" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:46px;">institutions.</div></div> | |
CY2022Q1 | us-gaap |
Bank Owned Life Insurance
BankOwnedLifeInsurance
|
42000000.0 | USD |
CY2022Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div id="TextBlockContainer231" style="position:relative;font-family:'Arial';font-size:13.28px;color:#000000;line-height:normal;width:735px;height:63px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2890" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Reclassifications </div><div id="a2893" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:31px;">Certain<div style="display:inline-block;width:9px"> </div>amounts<div style="display:inline-block;width:9px"> </div>in<div style="display:inline-block;width:8px"> </div>the<div style="display:inline-block;width:9px"> </div>Consolidated<div style="display:inline-block;width:9px"> </div>Financial<div style="display:inline-block;width:9px"> </div>Statements<div style="display:inline-block;width:9px"> </div>have<div style="display:inline-block;width:9px"> </div>been<div style="display:inline-block;width:9px"> </div>reclassified<div style="display:inline-block;width:9px"> </div>to<div style="display:inline-block;width:8px"> </div>conform<div style="display:inline-block;width:9px"> </div>to<div style="display:inline-block;width:9px"> </div>the<div style="display:inline-block;width:9px"> </div>current </div><div id="a2900" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:46px;">presentation. Reclassifications had no impact on the net income<div style="display:inline-block;width:5px"> </div>or stockholders’ equity of the Company.</div></div> | |
CY2022Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
419190000 | USD |
CY2022Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
602000 | USD |
CY2022Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
27578000 | USD |
CY2022Q1 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
122361000 | USD |
CY2022Q1 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
|
9671000 | USD |
CY2022Q1 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
112690000 | USD |
CY2021Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
405853000 | USD |
CY2021Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
2982000 | USD |
CY2021Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
7293000 | USD |
CY2021Q4 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
122658000 | USD |
CY2021Q4 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
|
14000 | USD |
CY2022Q1 | us-gaap |
Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
|
137000 | USD |
CY2021Q1 | us-gaap |
Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
|
13000 | USD |
CY2022Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
21000 | USD |
CY2021Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
62000 | USD |
CY2022Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
1995000 | USD |
CY2022Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
2014000 | USD |
CY2022Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
2007000 | USD |
CY2022Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
2003000 | USD |
CY2022Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
10518000 | USD |
CY2022Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
10509000 | USD |
CY2022Q1 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
|
11242000 | USD |
CY2022Q1 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
10521000 | USD |
CY2022Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
29019000 | USD |
CY2022Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
29131000 | USD |
CY2022Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
|
25144000 | USD |
CY2022Q1 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
|
22114000 | USD |
CY2022Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
419190000 | USD |
CY2022Q1 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
112690000 | USD |
CY2022Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
303364000 | USD |
CY2022Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
20821000 | USD |
CY2022Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
137679000 | USD |
CY2022Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
15525000 | USD |
CY2022Q1 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
441043000 | USD |
CY2022Q1 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
36346000 | USD |
CY2021Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
311459000 | USD |
CY2021Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
5381000 | USD |
CY2021Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
110794000 | USD |
CY2021Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
4095000 | USD |
CY2021Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
422253000 | USD |
CY2021Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
9476000 | USD |
CY2022Q1 | us-gaap |
Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue
|
20000000.0 | USD |
CY2022Q1 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
|
1258971000 | USD |
CY2022Q1 | uscb |
Percent Of Total Loans
PercentOfTotalLoans
|
1.000 | pure |
CY2021Q4 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
|
1191659000 | USD |
CY2021Q4 | uscb |
Percent Of Total Loans
PercentOfTotalLoans
|
1.000 | pure |
CY2022Q1 | us-gaap |
Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
|
583000 | USD |
CY2021Q4 | us-gaap |
Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
|
1578000 | USD |
CY2022Q1 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
1258388000 | USD |
CY2021Q4 | us-gaap |
Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
|
1190081000 | USD |
CY2022Q1 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
15074000 | USD |
CY2021Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
15057000 | USD |
CY2022Q1 | us-gaap |
Loans Pledged As Collateral
LoansPledgedAsCollateral
|
171400000 | USD |
CY2021Q4 | us-gaap |
Loans Pledged As Collateral
LoansPledgedAsCollateral
|
185100000 | USD |
CY2021Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
15057000 | USD |
CY2022Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
38000 | USD |
CY2022Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
21000 | USD |
CY2022Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
15074000 | USD |
CY2020Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
15086000 | USD |
CY2021Q1 | us-gaap |
Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
|
160000 | USD |
CY2021Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
92000 | USD |
CY2021Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
9000 | USD |
CY2021Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
15009000 | USD |
CY2022Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
|
335000 | USD |
CY2022Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
|
14739000 | USD |
CY2022Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
15074000 | USD |
CY2022Q1 | us-gaap |
Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
|
8309000 | USD |
CY2022Q1 | us-gaap |
Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
|
1250662000 | USD |
CY2022Q1 | us-gaap |
Notes Receivable Gross
NotesReceivableGross
|
1258971000 | USD |
CY2021Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
|
360000 | USD |
CY2021Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
|
14697000 | USD |
CY2021Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
15057000 | USD |
CY2021Q4 | us-gaap |
Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
|
10067000 | USD |
CY2021Q4 | us-gaap |
Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
|
1181592000 | USD |
CY2021Q4 | us-gaap |
Notes Receivable Gross
NotesReceivableGross
|
1191659000 | USD |
CY2022Q1 | us-gaap |
Notes Receivable Gross
NotesReceivableGross
|
1258971000 | USD |
CY2021Q4 | us-gaap |
Notes Receivable Gross
NotesReceivableGross
|
1191659000 | USD |
CY2022Q1 | uscb |
Financing Receivable Including90 Days Or More Past Due Still Accruing And Excluding Non Accrual Before Allowance For Credit Loss
FinancingReceivableIncluding90DaysOrMorePastDueStillAccruingAndExcludingNonAccrualBeforeAllowanceForCreditLoss
|
1258971000 | USD |
CY2022Q1 | us-gaap |
Notes Receivable Gross
NotesReceivableGross
|
1258971000 | USD |
CY2021Q4 | uscb |
Financing Receivable Including90 Days Or More Past Due Still Accruing And Excluding Non Accrual Before Allowance For Credit Loss
FinancingReceivableIncluding90DaysOrMorePastDueStillAccruingAndExcludingNonAccrualBeforeAllowanceForCreditLoss
|
1190469000 | USD |
CY2021Q4 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
1190000 | USD |
CY2021Q4 | us-gaap |
Notes Receivable Gross
NotesReceivableGross
|
1191659000 | USD |
CY2022Q1 | us-gaap |
Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
|
0 | USD |
CY2021Q1 | us-gaap |
Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
|
0 | USD |
CY2022Q1 | us-gaap |
Interest Income Financing Receivable Before Allowance For Credit Loss
InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss
|
0 | USD |
CY2021Q1 | us-gaap |
Interest Income Financing Receivable Before Allowance For Credit Loss
InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss
|
7000 | USD |
CY2022Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
|
3810000 | USD |
CY2022Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
|
3804000 | USD |
CY2021Q4 | us-gaap |
Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
|
5717000 | USD |
CY2021Q4 | us-gaap |
Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
|
5730000 | USD |
CY2022Q1 | us-gaap |
Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
|
4499000 | USD |
CY2022Q1 | us-gaap |
Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
|
4464000 | USD |
CY2022Q1 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
335000 | USD |
CY2021Q4 | us-gaap |
Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
|
4350000 | USD |
CY2021Q4 | us-gaap |
Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
|
4315000 | USD |
CY2021Q4 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
360000 | USD |
CY2022Q1 | us-gaap |
Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
|
8309000 | USD |
CY2022Q1 | us-gaap |
Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
|
8268000 | USD |
CY2022Q1 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
335000 | USD |
CY2021Q4 | us-gaap |
Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
|
10067000 | USD |
CY2021Q4 | us-gaap |
Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
|
10045000 | USD |
CY2021Q4 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
360000 | USD |
CY2022Q1 | us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
9187000 | USD |
CY2021Q1 | us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
10694000 | USD |
CY2022Q1 | us-gaap |
Loans And Leases Receivable Impaired Troubled Debt Interest Income
LoansAndLeasesReceivableImpairedTroubledDebtInterestIncome
|
91000 | USD |
CY2021Q1 | us-gaap |
Loans And Leases Receivable Impaired Troubled Debt Interest Income
LoansAndLeasesReceivableImpairedTroubledDebtInterestIncome
|
109000 | USD |
CY2022Q1 | us-gaap |
Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
|
8309000 | USD |
CY2021Q4 | us-gaap |
Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
|
8876000 | USD |
CY2022Q1 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
335000 | USD |
CY2021Q4 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
360000 | USD |
CY2022Q1 | us-gaap |
Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
|
0 | USD |
CY2021Q4 | us-gaap |
Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
|
0 | USD |
CY2022Q1 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
1442000 | USD |
CY2021Q1 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
1235000 | USD |
CY2022Q1 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
416000 | USD |
CY2021Q1 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
263000 | USD |
CY2022Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
1858000 | USD |
CY2021Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
1498000 | USD |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1858000 | USD |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1498000 | USD |
CY2021Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2022Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2022Q1 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
1409000 | USD |
CY2021Q1 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
1319000 | USD |
CY2022Q1 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
289000 | USD |
CY2021Q1 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
220000 | USD |
CY2022Q1 | uscb |
Effective Income Tax Rate Reconciliation Bank Owned Life Insurance
EffectiveIncomeTaxRateReconciliationBankOwnedLifeInsurance
|
67000 | USD |
CY2021Q1 | uscb |
Effective Income Tax Rate Reconciliation Bank Owned Life Insurance
EffectiveIncomeTaxRateReconciliationBankOwnedLifeInsurance
|
42000 | USD |
CY2022Q1 | us-gaap |
Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
|
227000 | USD |
CY2021Q1 | us-gaap |
Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
|
1000 | USD |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1858000 | USD |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1498000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
34929000 | USD |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
CY2022Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
CY2021Q1 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
0 | USD |
CY2022Q1 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
0 | USD |
CY2022Q1 | uscb |
Tieronecommonequityrequiredforcapitaladequacy
Tieronecommonequityrequiredforcapitaladequacy
|
60426000 | USD |
CY2022Q1 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
27731000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
28819000 | USD |
CY2022Q1 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
|
3820000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
|
3816000 | USD |
CY2022Q1 | uscb |
Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
|
3407000 | USD |
CY2021Q4 | uscb |
Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
|
3595000 | USD |
CY2022Q1 | us-gaap |
Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
|
6606000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
|
817000 | USD |
CY2022Q1 | uscb |
Deferred Tax Assets Deferred Loan Fees
DeferredTaxAssetsDeferredLoanFees
|
148000 | USD |
CY2021Q4 | uscb |
Deferred Tax Assets Deferred Loan Fees
DeferredTaxAssetsDeferredLoanFees
|
400000 | USD |
CY2022Q1 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
106000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
361000 | USD |
CY2022Q1 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
264000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
241000 | USD |
CY2022Q1 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
195000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
600000 | USD |
CY2022Q1 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
142000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
2000 | USD |
CY2022Q1 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
42419000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
38651000 | USD |
CY2022Q1 | uscb |
Deferred Tax Liability Lease Right Of Use Asset
DeferredTaxLiabilityLeaseRightOfUseAsset
|
3407000 | USD |
CY2021Q4 | uscb |
Deferred Tax Liability Lease Right Of Use Asset
DeferredTaxLiabilityLeaseRightOfUseAsset
|
3595000 | USD |
CY2022Q1 | us-gaap |
Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
|
152000 | USD |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
|
127000 | USD |
CY2022Q1 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
3559000 | USD |
CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
3722000 | USD |
CY2022Q1 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
38860000 | USD |
CY2021Q4 | us-gaap |
Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
|
75094000 | USD |
CY2021Q4 | us-gaap |
Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
|
0.0600 | pure |
CY2021Q4 | us-gaap |
Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
|
100125000 | USD |
CY2022Q1 | us-gaap |
Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
|
0.0600 | pure |
CY2021Q4 | us-gaap |
Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
|
0.0800 | pure |
CY2021Q4 | uscb |
Tier One Common Equity
TierOneCommonEquity
|
171484000 | USD |
CY2022Q1 | uscb |
Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
|
0.0450 | pure |
CY2022Q1 | uscb |
Tieronecommonequityrequiredtobewellcapitalized
Tieronecommonequityrequiredtobewellcapitalized
|
87282000 | USD |
CY2021Q4 | uscb |
Excesstieronecommonequitytoriskweightedassets
Excesstieronecommonequitytoriskweightedassets
|
0.1370 | pure |
CY2021Q4 | uscb |
Tieronecommonequityrequiredforcapitaladequacy
Tieronecommonequityrequiredforcapitaladequacy
|
56321000 | USD |
CY2022Q1 | us-gaap |
Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
|
107425000 | USD |
CY2021Q4 | uscb |
Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
|
0.0450 | pure |
CY2021Q4 | uscb |
Tieronecommonequityrequiredtobewellcapitalized
Tieronecommonequityrequiredtobewellcapitalized
|
81352000 | USD |
CY2022Q1 | us-gaap |
Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
|
0.0800 | pure |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
959667 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
10.87 | |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y4M24D | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
10000 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
14.12 | |
CY2022Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
9000 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
11.35 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
960667 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
10.90 | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y1M6D | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
322667 | shares |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
9.08 | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y9M18D | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
1693000 | USD |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
339667 | shares |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
9.37 | |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y1M6D | |
CY2021Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
64000 | shares |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
8.91 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
403667 | shares |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
9.29 | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y1M6D | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
243666 | shares |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
8.73 | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y3M18D | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
208000 | USD |
CY2022Q1 | uscb |
Tier One Common Equity
TierOneCommonEquity
|
179243000 | USD |
CY2022Q1 | us-gaap |
Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
|
131036000 | USD |
CY2021Q4 | us-gaap |
Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
|
141297000 | USD |
CY2022Q1 | uscb |
Excesstieronecommonequitytoriskweightedassets
Excesstieronecommonequitytoriskweightedassets
|
0.1335 | pure |
CY2022Q1 | uscb |
Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
|
0.0650 | pure |
CY2021Q4 | uscb |
Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
|
0.0650 | pure |
CY2021Q4 | us-gaap |
Tier One Leverage Capital
TierOneLeverageCapital
|
171484000 | USD |
CY2022Q1 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
1.00 | |
CY2022Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q1 | us-gaap |
Dividends Preferred Stock Cash
DividendsPreferredStockCash
|
781000 | USD |
CY2022Q1 | uscb |
Percent Used To Calculate Income Allocation
PercentUsedToCalculateIncomeAllocation
|
0.20 | pure |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4854000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4781000 | USD |
CY2021Q1 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
781000 | USD |
CY2022Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
4854000 | USD |
CY2021Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
4000000 | USD |
CY2022Q1 | us-gaap |
Banking Regulation Capital Conservation Buffer Capital Conserved Minimum
BankingRegulationCapitalConservationBufferCapitalConservedMinimum
|
0.025 | pure |
CY2022Q1 | us-gaap |
Capital
Capital
|
194564000 | USD |
CY2022Q1 | us-gaap |
Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
|
0.1449 | pure |
CY2022Q1 | us-gaap |
Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
|
107425000 | USD |
CY2022Q1 | us-gaap |
Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
|
0.0800 | pure |
CY2022Q1 | us-gaap |
Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
|
134281000 | USD |
CY2022Q1 | us-gaap |
Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
|
0.1000 | pure |
CY2022Q1 | us-gaap |
Tier One Risk Based Capital
TierOneRiskBasedCapital
|
179243000 | USD |
CY2022Q1 | us-gaap |
Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
|
0.1335 | pure |
CY2022Q1 | us-gaap |
Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
|
80568000 | USD |
CY2022Q1 | us-gaap |
Tier One Leverage Capital
TierOneLeverageCapital
|
179243000 | USD |
CY2022Q1 | us-gaap |
Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
|
0.0947 | pure |
CY2022Q1 | us-gaap |
Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
|
75681000 | USD |
CY2022Q1 | us-gaap |
Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
|
0.0400 | pure |
CY2022Q1 | us-gaap |
Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
|
94601000 | USD |
CY2022Q1 | us-gaap |
Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
|
0.0500 | pure |
CY2021Q4 | us-gaap |
Capital
Capital
|
186735000 | USD |
CY2021Q4 | us-gaap |
Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
|
0.1492 | pure |
CY2021Q4 | us-gaap |
Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
|
100125000 | USD |
CY2021Q4 | us-gaap |
Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
|
0.0800 | pure |
CY2021Q4 | us-gaap |
Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
|
125157000 | USD |
CY2021Q4 | us-gaap |
Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
|
0.1000 | pure |
CY2021Q4 | us-gaap |
Tier One Risk Based Capital
TierOneRiskBasedCapital
|
171484000 | USD |
CY2021Q4 | us-gaap |
Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
|
0.0955 | pure |
CY2021Q4 | us-gaap |
Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
|
71825000 | USD |
CY2021Q4 | us-gaap |
Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
|
0.0400 | pure |
CY2021Q4 | us-gaap |
Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
|
89781000 | USD |
CY2021Q4 | us-gaap |
Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
|
0.0500 | pure |